Related Experiment Video
Updated: Oct 29, 2025
05:12
Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
1.1K
Current Therapies for Alcohol-Associated Hepatitis.
1Department of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, 676 North Street Clair, Suite 1900, Chicago, IL 60611, USA.
Clinics in Liver Disease
|July 7, 2021
Summary
Alcohol-associated hepatitis has poor outcomes, with limited treatments beyond corticosteroids. Further research is needed for agents like granulocyte colony-stimulating factor, alongside abstinence and nutrition, to improve patient survival.
Area of Science:
- Hepatology
- Gastroenterology
- Internal Medicine
Background:
- Alcohol-associated hepatitis (AH) presents significant challenges due to poor patient outcomes, particularly in severe cases.
- Current therapeutic strategies for AH are limited, with corticosteroids remaining the primary treatment modality.
- Despite extensive research into various agents, effective treatments for AH are still lacking.
Purpose of the Study:
- To review current treatment options for alcohol-associated hepatitis.
- To explore emerging therapies and adjuncts for improving outcomes in AH patients.
- To highlight the importance of supportive care and novel treatment strategies.
Main Methods:
- Literature review of existing studies on alcohol-associated hepatitis treatments.
- Analysis of the efficacy and limitations of current therapies, including corticosteroids.
- Evaluation of potential alternative treatments such as granulocyte colony-stimulating factor.
Main Results:
- Corticosteroids are the current standard of care but have limitations.
- Granulocyte colony-stimulating factor shows promise but requires further investigation in diverse patient groups.
- Alcohol abstinence and nutritional support are crucial, often overlooked, adjuncts for improving outcomes.
Conclusions:
- Treatment options for severe alcohol-associated hepatitis remain limited.
- Emerging therapies like granulocyte colony-stimulating factor warrant further study.
- Optimizing nutrition, ensuring alcohol abstinence, and considering liver transplantation or clinical trials are vital for managing AH.
Related Concept Videos
01:27CNS Depressants: Alcohol and Nicotine
597
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
597
01:26Diseases of the Liver and Gallbladder
1.5K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.5K
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
38
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
38
01:23Gastritis III: Clinical Manifestations and Management
642
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
642
01:28Drug Therapy
129
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
129
01:29Chronic Pancreatitis II: Collaborative Care
151
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
151